O

Oxygenta Pharmaceutical Ltd 524636.BO

₹55.50 ₹0.75 (1.33%) 1D

Last Updated: May 15, 12:00 AM·BSE

524636.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 07, 2026

Report Source: 2026 2nd Quarter Report

O

Oxygenta Pharmaceutical Ltd. Stock Analysis 524636.BO

India Health Care Nano Cap Report:
Oxygenta Pharmaceutical Ltd. engages in the development and manufacture of bulk drugs. The company operates in the pharmaceutical segment. The firm also sells the products to its related companies engaged in the manufacture of formulations. Its active pharmaceutical ingredients (API) products include pantoprazole sodium, vildagliptin, telmisartan, lacosamide, and sertraline hydrochloride. The Company’s chemical products include 3-Amino-1-adamantanol, (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile, 2-N-Propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole, Isobutyramide, 4-Aminobenzonitrile, Valeronitrile and others. Its manufacturing facilities are situated at Sadasivapet Mandal, Sangareddy District, Telangana State.
Read More

Key Statistics of Oxygenta Pharmaceutical Ltd (524636.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹55.40₹57.44

Today's Open

₹56.25

Volume

6376.00

P/E Ratio (TTM)

-

52 Week Range

₹45.30₹133.50

Market Cap

1.97B

Avg. Volume

6516.73

Dividend Yield

-

Financial Metrics & Statements of Oxygenta Pharmaceutical Ltd (524636.BO)

FAQ's for Oxygenta Pharmaceutical Ltd (524636.BO)

  • According to Musaffa’s Shariah screening methodology, Oxygenta Pharmaceutical Ltd (524636.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.